Inhibition of vascular smooth muscle growth via signaling crosstalk between amp-activated protein kinase and camp-dependent protein kinase

Frontiers in Physiology

Volumn 3 OCT, Issue , 2012, Pages

  Stone, Joshua D ^a   Narine, Avinash ^a   Tulis, David A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Ampk; Migration; Proliferation; Protein kinase A; Protein phosphatase

Indexed keywords

EID: 84870901689     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00409     Document Type: Article

References (55)

1. Adderley, S. P., Joshi, C. N., Martin, D. N., and Tulis, D. A. (2012). Phosphodiesterases regulate BAY 41-2272-induced VASP phosphorylation in vascular smooth muscle cells. Front Pharmacol 3:10. doi: 10.3389/fphar.2012.00010
2. Browner, N. C, Dey, N. B., Bloch, K. D., and Lincoln, T. M. (2004). Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J. Biol Chem. 279, 46631-46636.
3. Cai, Y., Teng, X., Pan, C. S., Duan, X. H., Tang, C. S., and Qi, Y. F. (2010). Adrenomedullinup-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin. 31, 1359-1366.
4. Chang, M. Y., Ho, F. M., Wang, J. S., Kang, H. C, Chang, Y., Ye, Z. X., et al. (2010). AICAR induces cyclo oxygenase-2expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Biochem. Pharmacol 80, 1210-1220.
5. Cohen, P., and Hardie, D. G. (1991). The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase. Biochim. Biophys. Acta 1094, 292-299.
6. D'Souza, F. M., Sparks, R. L., Chen, H., Kadowitz, P. J., and Jeter, J. R. Jr. (2003). Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am. J. Physiol Cell Physiol. 284, C191-C199.
7. Djouder, N., Tuerk, R. D., Suter, M., Salvioni, P., Thali, R. F., Scholz, R., et al. (2010). PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBOJ. 29, 469-481.
8. Durante, W., Schini, V. B., Catovsky, S., Kroll, M. H., Vanhoutte, P. M., and Schafer, A. I. (1993). Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Am. J. Physiol. 264, H617-H624.
9. Dyck, J. R., Kudo, N., Barr, A. J., Davies, S. P., Hardie, D. G., and Lopaschuk, G. D. (1999). Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5;-AMP activated protein kinase. Eur. J. Biochem. 262, 184-190.
10. Eckert, R. E., and Jones, S. L. (2007). Regulation of VASP serine 157 phosphorylation in human neu-trophils after stimulation by a chemoattractant. J. Leukoc. Biol. 82, 1311-1321.
11. Goirand, F., Solar, M., Athea, Y., Viollet, B., Mateo, P., Fortin, D., et al. (2007). Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. J. Physiol. 581, 1163-1171.
12. Han, J. H., Ahn, Y. H., Choi, K. Y., and Hong, S. H. (2009). Involvement of AMP-activated protein kinase and p38 mitogen-activated protein kinase in 8-Cl-cAMP-induced growth inhibition. J. Cell. Physiol. 218, 104-112.
13. Handa, N., Takagi, T., Saijo, S., Kishishita, S., Takaya, D., Toyama, M., et al. (2011). Structural basis for compound C inhibition of the human AMP-activated protein kinase alpha2 subunit kinase domain. Acta Crystallogr. D Biol. Crystallogr. 67, 480-487.
14. Hardie, D. G. (2007). AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774-785.
15. Hardie, D. G. (2011). AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 25, 1895-1908.
16. Hewer, R. C., Sala-Newby, G. B., Wu, Y. J., Newby, A. C., and Bond, M. (2011). PKA and Epac synergisti-cally inhibit smooth muscle cell proliferation. J. Mol. Cell. Cardiol. 50, 87-98.
17. Hurley, R. L., Barre, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means, A. R., et al. (2006). Regulation of AMP-activated protein kinase by multisite phospho-rylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281, 36662-36672.
18. Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., et al. (2005). Adenosine monophosphate-activated pro-tein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 97, 837-844.
19. Insull, W. Jr. (2009). The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am. J. Med. 122, S3-S14.
20. Janssens, V., and Goris, J. (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353, 417-439.
21. Joshi, C. N., Martin, D. N., Fox, J. C., Mendelev, N. N., Brown, T. A., and Tulis, D. A. (2011). The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the PKA and PKG pathways. J. Pharmacol. Exp. Ther. 339, 394-402.
22. Joshi, C. N., Martin, D. N., Shaver, P., Madamanchi, C., Muller-Borer, B. J., and Tulis, D. A. (2012). Control of vascular smooth muscle cell growth by connexin 43. Front. Physio. 3:220. doi: 10.3389/fphys.2012.00220
23. Kawaguchi, T., Takenoshita, M., Kabashima, T., and Uyeda, K. (2001). Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphoryla-tion/dephosphorylation of the carbohydrate response element binding protein. Proc. Natl. Acad. Sci. U.S.A. 98, 13710-13715.
24. Kemp, B. E., Stapleton, D., Campbell, D. J., Chen, Z. P., Murthy, S., Walter, M., et al. (2003). AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 31, 162-168.
25. Kim, J. E., Song, S. E., Kim, Y. W., Kim, J. Y., Park, S. C., Park, Y. K., et al. (2010). Adiponectin inhibits palmitate-induced apopto-sis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. J. Endocrinol. 207, 35-44.
26. Lin, Y. Y., Kiihl, S., Suhail, Y., Liu, S. Y., Chou, Y. H., Kuang, Z., et al. (2012). Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 482, 251-255.
27. Liu, Y., Dolence, J., Ren, J., Rao, M., and Sreejayan, N. (2008). Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function. J. Cardiovasc. Pharmacol. 52, 422-429.
28. Lucchi, S., Calebiro, D., De Filippis, T., Grassi, E. S., Borghi, M. O., and Persani, L. (2011). 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms. PLoS ONE 6:e20785. doi: 10.1371/journal.pone.0020785
29. Majesky, M. W. (1994). Neointima formation after acute vascular injury. Role of counteradhesive extracellular matrix proteins. Te x. He a r t In s t. J. 21, 78-85.
30. Mendelev, N. N., Williams, V. S., and Tulis, D. A. (2009). Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 53, 121-131.
31. Momcilovic, M., Hong, S. P., and Carlson, M. (2006). Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 281, 25336-25343.
32. Nagata, D., Takeda, R., Sata, M., Satonaka, H., Suzuki, E., Nagano, T., et al. (2004). AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110, 444-451.
33. Ning, J., Xi, G., and Clemmons, D. R. (2011). Suppression of AMPK activation via S485 phosphoryla-tion by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. Endocrinology 152, 3143-3154.
34. Pastula, C., Johnson, I., Beechem, J. M., and Patton, W. F. (2003). Development of fluorescence-based selective assays for serine/threonine and tyrosine phosphatases. Comb. Chem. High Throughput Screen. 6, 341-346.
35. Peyton, K. J., Yu, Y., Yates, B., Shebib, A.R., Liu, X. M., Wang, H., et al. (2011). Compound C inhibits vascular smooth muscle cell pro liferation and migration in an AMP-activated protein kinase-independent fashion. J. Pharmacol. Exp. Ther. 338, 476-484.
36. Richter, E. A., Nielsen, J. N., Jorgensen, S. B., Frosig, C., and Wojtaszewski, J. F. (2003). Signalling to glucose transport in skeletal muscle during exercise. Acta Physiol. Scand. 178, 329-335.
37. Rossoni, L. V., Wareing, M., Wenceslau, C.F., Al-Abri, M., Cobb, C., and Austin, C. (2011). Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesen-teric resistance arteries. Clin. Sci. (Lond.) 121, 449-458.
38. Rubin, L. J., Magliola, L., Feng, X., Jones, A. W., and Hale, C. C. (2005). Metabolic activation of AMP kinase in vascular smooth muscle. J. Appl. Physiol. 98, 296-306.
39. Sanders, M. J., Grondin, P. O., Hegarty, B.D., Snowden, M. A., and Carling, D. (2007). Investigating the mech anism for AMP activation of the AMP-activated protein kinase cas cade. Biochem. J. 403, 139-148.
40. Shen, J., Smith, R. A., Stoll, V. S., Edalji, R., Jakob, C., Walter, K., et al. (2004). Characterization of protein kinase a phosphorylation: multi-technique approach to phosphate mapping. Anal. Biochem. 324, 204-218.
41. Shoji, S., Ericsson, L. H., Walsh, K. A., Fischer, E. H., and Titani, K. (1983). Amino acid sequence of the catalytic subunit of bovine type II adenosine cyclic 3;, 5; -phosphate dependent protein kinase. Biochemistry 22, 3702-3709.
42. Song, P., Wang, S., He, C, Liang, B., Viollet, B., and Zou, M. H. (2011). AMPKalpha2 deletion exacerbates neointima formation by upregulat-ing Skp2 in vascular smooth muscle cells. Circ. Res. 109, 1230-1239.
43. Steinberg, R. A., Cauthron, R. D., Symcox, M. M., and Shuntoh, H. (1993). Auto activation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197. Mol. Cell. Biol. 13, 2332-2341.
44. Stricker, S. A., Swiderek, L., and Nguyen, T. (2010). Stimulators of AMP-activated kinase (AMPK) inhibit seawater- but not cAMP-induced oocyte maturation in a marine worm: implications for interactions between cAMP and AMPK signaling. Mol. Reprod. Dev. 77, 497-510.
45. Sung, J. Y., and Choi, H. C. (2011). Aspirin-induced AMP-activated protein kinase activation regulates the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 408, 312-317.
46. Tang, Y. C., Williams, B. R., Siegel, J. J., and Amon, A. (2011). Identification of aneuploidy-selective antipro-liferation compounds. Cell 144, 499-512.
47. Tulis, D. A. (2008). Novel therapies for cyclic GMP control of vascular smooth muscle growth. Am. J. Ther. 15, 551-564.
48. Tulis, D. A., Durante, W., Peyton, K. J., Chapman, G. B., Evans, A. J., and Schafer, A. I. (2000). YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem. Biophys. Res. Commun. 279, 646-652.
49. Valero, M. S., Pereboom, D., Barcelo-Batllory, S., Brines, L., Garay, R. P., and Alda, J. O. (2011). Protein kinase A signalling is involved in the relaxant responses to the selective beta-oestrogen receptor agonist diarylpropionitrile in rat aortic smooth muscle in vitro. J. Pharm. Pharmacol. 63, 222-229.
50. Wang, M., Monticone, R. E., and Lakatta, E. G. (2010). Arterial aging: a journey into subclinical arterial disease. Curr. Opin. Nephrol. Hypertens. 19, 201-207.
51. Watt, M. J., Holmes, A. G., Pinnamaneni, S. K., Garnham, A. P., Steinberg, G. R., Kemp, B. E., et al. (2006). Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 290, E500-E508.
52. Witters, L. A., Nordlund, A. C, and Marshall, L. (1991). Regulation of intracellular acetyl-CoA carboxylase by ATP depletors mimics the action of the 5;-AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 181, 1486-1492.
53. Woods, A., Vertommen, D., Neumann, D., Turk, R., Bayliss, J., Schlattner, U., et al. (2003). Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J. Biol. Chem. 278, 28434-28442.
54. Yang, X. P., Thomas, D. P., Zhang, X. C, Culver, B. W., Alexander, B. M., Murdoch, W. J., et al. (2006). Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 26, 85-90.
55. Zhang, S., Liu, Y, Guo, S., Zhang, J., Chu, X., Jiang, C, et al. (2010). Vasoactive intestinal polypeptide relaxes isolated rat pulmonary artery rings through two distinct mechanisms. J. Physiol. Sci. 60, 389-397.